loading
Papers Papers/2022 Papers Papers/2022

Research.Publish.Connect.

Paper

Authors: Mazid Osseni 1 ; Prudencio Tossou 2 ; François Laviolette 1 and Jacques Corbeil 1 ; 3

Affiliations: 1 GRAAL, Institute Intelligence and Data, Department of Computer Science and Software Engineering, Université Laval, Quebec, QC, Canada ; 2 Valence AI Discovery, Montréal, QC, Canada ; 3 Department of Molecular Medicine, Université Laval, Quebec, QC, Canada

Keyword(s): Multiclass Classification, Cancer, Multi-Omics Analysis, Transformer Model, Precision Medicine.

Abstract: Motivation: Breakthroughs in high-throughput technologies and machine learning methods have enabled the shift towards multi-omics modelling as the preferred means to understand the mechanisms underlying biological processes. Machine learning enables and improves complex disease prognosis in clinical settings. However, most multi-omic studies primarily use transcriptomics and epigenomics due to their over-representation in databases and their early technical maturity compared to others omics. For complex phenotypes and mechanisms, not leveraging all the omics despite their varying degree of availability can lead to a failure to understand the underlying biological mechanisms and leads to less robust classifications and predictions. Results: We proposed MOT (Multi-Omic Transformer), a deep learning based model using the transformer architecture, that discriminates complex phenotypes (herein cancer types) based on five omics data types: transcriptomics (mRNA and miRNA), epigenomics (DNA methylation), copy number variations (CNVs), and proteomics. This model achieves an F1-score of 98:37% among 33 tumour types on a test set without missing omics views and an F1-score of 96:74% on a test set with missing omics views. It also identifies the required omic type for the best prediction for each phenotype and therefore could guide clinical decision-making when acquiring data to confirm a diagnostic. The newly introduced model can integrate and analyze five or more omics data types even with missing omics views and can also identify the essential omics data for the tumour multiclass classification tasks. It confirms the importance of each omic view. Combined, omics views allow a better differentiation rate between most cancer diseases. Our study emphasized the importance of multi-omic data to obtain a better multiclass cancer classification. Availability and implementation: MOT source code is available at https://github.com/dizam92/multiomic predictions. (More)

CC BY-NC-ND 4.0

Sign In Guest: Register as new SciTePress user now for free.

Sign In SciTePress user: please login.

PDF ImageMy Papers

You are not signed in, therefore limits apply to your IP address 3.12.120.178

In the current month:
Recent papers: 100 available of 100 total
2+ years older papers: 200 available of 200 total

Paper citation in several formats:
Osseni, M.; Tossou, P.; Laviolette, F. and Corbeil, J. (2023). MOT: A Multi-Omics Transformer for Multiclass Classification Tumour Types Predictions. In Proceedings of the 16th International Joint Conference on Biomedical Engineering Systems and Technologies (BIOSTEC 2023) - BIOINFORMATICS; ISBN 978-989-758-631-6; ISSN 2184-4305, SciTePress, pages 252-261. DOI: 10.5220/0011780100003414

@conference{bioinformatics23,
author={Mazid Osseni. and Prudencio Tossou. and Fran\c{C}ois Laviolette. and Jacques Corbeil.},
title={MOT: A Multi-Omics Transformer for Multiclass Classification Tumour Types Predictions},
booktitle={Proceedings of the 16th International Joint Conference on Biomedical Engineering Systems and Technologies (BIOSTEC 2023) - BIOINFORMATICS},
year={2023},
pages={252-261},
publisher={SciTePress},
organization={INSTICC},
doi={10.5220/0011780100003414},
isbn={978-989-758-631-6},
issn={2184-4305},
}

TY - CONF

JO - Proceedings of the 16th International Joint Conference on Biomedical Engineering Systems and Technologies (BIOSTEC 2023) - BIOINFORMATICS
TI - MOT: A Multi-Omics Transformer for Multiclass Classification Tumour Types Predictions
SN - 978-989-758-631-6
IS - 2184-4305
AU - Osseni, M.
AU - Tossou, P.
AU - Laviolette, F.
AU - Corbeil, J.
PY - 2023
SP - 252
EP - 261
DO - 10.5220/0011780100003414
PB - SciTePress